FDA Blocked Melanoma Drug as Confusion Reigned Under Makary
A third of patients in a clinical trial had tumors shrink while taking a genetically engineered treatment known as RP1.
The independent source for health policy research, polling, and news.
21 - 40 of 540 Results
A third of patients in a clinical trial had tumors shrink while taking a genetically engineered treatment known as RP1.
He tested robotic hands on a heart surgery patient and chewed on microgreens in Ohio, but Health and Human Services Secretary Robert F. Kennedy Jr. couldn鈥檛 dodge questions about the Trump administration鈥檚 more controversial policies.
For years, the Department of Health and Human Services built standards to make sure electronic health records were user-friendly and offered transparent advice to doctors. Now they鈥檙e relaxing those standards, and doctors and critics in the hospital industry are worried.
Get our weekly newsletter, The Week in Brief, featuring a roundup of our original coverage, Fridays at 2 p.m. ET.
The backlash was immediate after the Trump administration served notice that hospitals and nursing homes should limit sugary drinks and dietary supplements in favor of what the Department of Health and Human Services terms 鈥渞eal food.鈥
A federal agency has dramatically slowed its review of visa waiver applications that allow international physicians completing U.S. training programs to stay in the country to work in underserved areas. The delay may send hundreds of doctors back to their home countries.
Patients are getting stuck in the emergency department for days while waiting for a spot in an inpatient ward.
After 吃瓜不打烊 reported that the Trump administration is seeking federal workers鈥 medical records, Democratic lawmakers are insisting that the Office of Personnel Management drop its request.
A funding notice for Title X shifts the program鈥檚 emphasis from contraception to fertility, family formation, and addressing conditions that could cause infertility, including endometriosis. Experts say these priorities overlook key demographic trends, epidemiology, prevention of unwanted pregnancies, and the nation's high maternal mortality.
Get our weekly newsletter, The Week in Brief, featuring a roundup of our original coverage, Fridays at 2 p.m. ET.
This week, the Trump administration won a court battle to delay a ruling on access to the abortion pill mifepristone, angering its own anti-abortion allies. Meanwhile, the president鈥檚 budget arrived on Capitol Hill, where lawmakers are unlikely to agree to its proposed cuts to Health and Human Services programs. Lauren Weber of The Washington Post, Alice Miranda Ollstein of Politico, and Maya Goldman of Axios join 吃瓜不打烊鈥 Julie Rovner to discuss these stories and more.
The administration is asking insurers that cover federal employees and retirees to hand over details about their medical visits, their pharmacy claims, and more.
Rosa Mar铆a Carranza has worked and paid taxes for more than two decades, but a provision in the GOP's One Big Beautiful Bill Act will make her and an estimated 100,000 other lawfully present immigrant seniors ineligible for Medicare. Now Carranza鈥檚 once secure retirement is in question.
Despite public opposition to the cuts they made to federal health programs in 2025, Republicans reportedly are considering more cuts to help pay for the war in Iran. Meanwhile, the Supreme Court ruled that Colorado cannot ban 鈥渃onversion therapy鈥 for LGBTQ+ minors. Jessie Hellmann of CQ Roll Call, Alice Miranda Ollstein of Politico, and Sandhya Raman of Bloomberg Law join 吃瓜不打烊鈥 Julie Rovner to discuss these stories and more. Also this week, Rovner interviews 吃瓜不打烊鈥 Elisabeth Rosenthal, who wrote the last two 鈥淏ill of the Month鈥 stories.
吃瓜不打烊 gives readers a chance to comment on a recent batch of stories.
Federal health officials have ordered states to reverify the immigration status of hundreds of thousands of Medicaid enrollees. After seven months, findings from five states show the reviews have uncovered few immigrants without legal status who are improperly receiving benefits.
The Trump administration faces the challenge of naming a new director of the Centers for Disease Control and Prevention who can both satisfy the Make America Healthy Again movement and get confirmed by the Senate. Meanwhile, a new Senate bill to rescind the approval of the abortion pill mifepristone is again elevating the abortion debate, which some Republicans would prefer to stay on the back burner until after the midterms. Shefali Luthra of The 19th, Lizzy Lawrence of Stat, and Rachel Cohrs Zhang of Bloomberg News join 吃瓜不打烊鈥 Julie Rovner to discuss the news. Also this week, Rovner interviews Georgetown University Law Center鈥檚 Katie Keith about the state of the Affordable Care Act on its 16th anniversary.
Jay Bhattacharya, head of the National Institutes of Health and interim leader of the Centers for Disease Control and Prevention, told the CDC staff, 鈥淚 know that it has been such a difficult year.鈥
Thousands of employees are gone and last summer鈥檚 shooting resonates still at the Centers for Disease Control and Prevention headquarters and among the large public health community in Atlanta.
漏 2026 KFF